Correlative studies of the Breast Cancer Index (HOXB13/IL17BR) and ER, PR, AR, AR/ER ratio and Ki67 for prediction of extended endocrine therapy benefit: a Trans-aTTom study

RT @BreastCancerNDX: New findings from the #TransaTTom study published in Breast Cancer Research are consistent with the established body o…

RT @BreastCancerNDX: New findings from the #TransaTTom study published in Breast Cancer Research are consistent with the established body o…

RT @BreastCancerNDX: Subset analysis from the Trans-aTTom study directly compared the Breast Cancer Index biomarker with traditional biomar…

New findings from the #TransaTTom study published in Breast Cancer Research are consistent with the established body of evidence that BCI (H/I biomarker) may predict benefit of extended-endocrine therapy. Read the study: https://t.co/1OpdOyJPW8 https://t.c